Henry County Memorial Hospital Hospice Medicare Approved Location: 1007 N 16th St Suite 220, New Castle, Indiana 47362 Phone: (765) 593-2389 |
News Archive
Shionogi today announced pivotal phase III study (COMPOSE I) results showing that once-daily treatment with naldemedine significantly improved opioid-induced constipation (OIC) compared to placebo in patients with chronic non-cancer pain.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, announced today that it has entered into an option agreement with The University of Texas M. D. Anderson Cancer Center relating to an immunotherapy targeting cancer stem cells (CSCs) which has demonstrated in pre-clinical animal models significant abilities to target and destroy CSCs.
RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.
A new study in the Journal of the American Medical Association found that emergency visit rates have increased at twice the rate of growth of the U.S. population from 1997 to 2007; Medicaid patients accounted for a large proportion of the increase, often coming with more severe illnesses and complications.
› Verified 8 days ago